LPA and familial hyperaldosteronism: A recent study carried out on 1.020 individuals including 252 clinically diagnosed hypercholesterolemia patients from the Familial Hypercholesterolemia (FH) Register Austria showed that the integration of polygenic scores with some LPA gene variants increases the proportion of individuals with a clearly defined disease by nearly 30% compared to standard scores [87].